Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
Shanghai Labway Clinical Laboratory Co Ltd
Cash from Investing Activities
Shanghai Labway Clinical Laboratory Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
|
Cash from Investing Activities
-¥398.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Investing Activities
-¥944.5m
|
CAGR 3-Years
25%
|
CAGR 5-Years
31%
|
CAGR 10-Years
14%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Investing Activities
¥1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Investing Activities
-¥1.5B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-11%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Investing Activities
-¥115.8m
|
CAGR 3-Years
-115%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Investing Activities
-¥2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-20%
|
See Also
What is Shanghai Labway Clinical Laboratory Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-398.5m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Labway Clinical Laboratory Co Ltd's Cash from Investing Activities amounts to -398.5m CNY.
What is Shanghai Labway Clinical Laboratory Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-37%